These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 16061852)
1. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Fernández CA; Yan L; Louis G; Yang J; Kutok JL; Moses MA Clin Cancer Res; 2005 Aug; 11(15):5390-5. PubMed ID: 16061852 [TBL] [Abstract][Full Text] [Related]
2. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. Yan L; Borregaard N; Kjeldsen L; Moses MA J Biol Chem; 2001 Oct; 276(40):37258-65. PubMed ID: 11486009 [TBL] [Abstract][Full Text] [Related]
3. Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9. Gupta K; Shukla M; Cowland JB; Malemud CJ; Haqqi TM Arthritis Rheum; 2007 Oct; 56(10):3326-35. PubMed ID: 17907186 [TBL] [Abstract][Full Text] [Related]
4. [Expression of matrix metalloproteinase-9 and its complex in the urine of breast cancer patients]. Shen ZZ; Zhao W; Gu J; Zhang ZQ; Yan L Zhonghua Wai Ke Za Zhi; 2003 Nov; 41(11):817-9. PubMed ID: 14703455 [TBL] [Abstract][Full Text] [Related]
5. Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism? Diamanti-Kandarakis E; Livadas S; Kandarakis SA; Margeli A; Papassotiriou I Eur J Endocrinol; 2008 Apr; 158(4):525-31. PubMed ID: 18362300 [TBL] [Abstract][Full Text] [Related]
6. Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease. Provatopoulou X; Gounaris A; Kalogera E; Zagouri F; Flessas I; Goussetis E; Nonni A; Papassotiriou I; Zografos G BMC Cancer; 2009 Nov; 9():390. PubMed ID: 19889214 [TBL] [Abstract][Full Text] [Related]
8. Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Tong Z; Kunnumakkara AB; Wang H; Matsuo Y; Diagaradjane P; Harikumar KB; Ramachandran V; Sung B; Chakraborty A; Bresalier RS; Logsdon C; Aggarwal BB; Krishnan S; Guha S Cancer Res; 2008 Aug; 68(15):6100-8. PubMed ID: 18676832 [TBL] [Abstract][Full Text] [Related]
9. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma. Barresi V; Reggiani-Bonetti L; Di Gregorio C; Vitarelli E; Ponz De Leon M; Barresi G Pathol Res Pract; 2011 Aug; 207(8):479-86. PubMed ID: 21726963 [TBL] [Abstract][Full Text] [Related]
10. Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells. Lee HJ; Lee EK; Lee KJ; Hong SW; Yoon Y; Kim JS Int J Cancer; 2006 May; 118(10):2490-7. PubMed ID: 16381001 [TBL] [Abstract][Full Text] [Related]
12. Urinary ADAM12 and MMP-9/NGAL complex detect the presence of gastric cancer. Shimura T; Dagher A; Sachdev M; Ebi M; Yamada T; Yamada T; Joh T; Moses MA Cancer Prev Res (Phila); 2015 Mar; 8(3):240-8. PubMed ID: 25591790 [TBL] [Abstract][Full Text] [Related]
13. Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Activity in Human Glioma Samples Predicts Tumor Presence and Clinical Prognosis. Liu MF; Hu YY; Jin T; Xu K; Wang SH; Du GZ; Wu BL; Li LY; Xu LY; Li EM; Xu HX Dis Markers; 2015; 2015():138974. PubMed ID: 26663949 [TBL] [Abstract][Full Text] [Related]
14. Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease. Tsai HT; Su PH; Lee TH; Tee YT; Lin LY; Yang SF; Wang PH Clin Chim Acta; 2011 Jun; 412(13-14):1252-6. PubMed ID: 21439274 [TBL] [Abstract][Full Text] [Related]
15. Urinary biomarkers predict brain tumor presence and response to therapy. Smith ER; Zurakowski D; Saad A; Scott RM; Moses MA Clin Cancer Res; 2008 Apr; 14(8):2378-86. PubMed ID: 18413828 [TBL] [Abstract][Full Text] [Related]
16. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. Kubben FJ; Sier CF; Hawinkels LJ; Tschesche H; van Duijn W; Zuidwijk K; van der Reijden JJ; Hanemaaijer R; Griffioen G; Lamers CB; Verspaget HW Eur J Cancer; 2007 Aug; 43(12):1869-76. PubMed ID: 17604154 [TBL] [Abstract][Full Text] [Related]
17. C/EBP ζ targets to neutrophil gelatinase-associated lipocalin (NGAL) as a repressor for metastasis of MDA-MB-231 cells. Wang L; Li H; Wang J; Gao W; Lin Y; Jin W; Chang G; Wang R; Li Q; Ma L; Pang T Biochim Biophys Acta; 2011 Oct; 1813(10):1803-13. PubMed ID: 21741997 [TBL] [Abstract][Full Text] [Related]
18. Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms. Folkesson M; Kazi M; Zhu C; Silveira A; Hemdahl AL; Hamsten A; Hedin U; Swedenborg J; Eriksson P Thromb Haemost; 2007 Aug; 98(2):427-33. PubMed ID: 17721627 [TBL] [Abstract][Full Text] [Related]
19. Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin. Serra R; Buffone G; Falcone D; Molinari V; Scaramuzzino M; Gallelli L; de Franciscis S Wound Repair Regen; 2013; 21(3):395-401. PubMed ID: 23531093 [TBL] [Abstract][Full Text] [Related]
20. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Bauer M; Eickhoff JC; Gould MN; Mundhenke C; Maass N; Friedl A Breast Cancer Res Treat; 2008 Apr; 108(3):389-97. PubMed ID: 17554627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]